课题基金 / 基金详情

Large-scale development of inhibitors to intracellular cancer targets using an integrated computational and combinatorial approach

Large-scale development of inhibitors to intracellular cancer targets using an integrated computational and combinatorial approach
使用集成计算和组合方法大规模开发细胞内癌症靶点的抑制剂
批准号:
252617
负责人:
Kim Philip M
金额:
$48.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-03-01 至 2017-03-01

项目摘要

项目成果

Kim Philip M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have seen great advances in the understanding of cancer. Likewise, our knowledge about how to manipulate proteins, the body's machinery, has greatly increased. However, the discovery of new drugs remains at a slow and, surprisingly, decreasing pace. Th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome targeting by highly accurate design of Zinc Fingers to enable novel therapeutics and research tools
  • 批准号:
    479699
  • 项目类别:
    Operating Grants
  • 资助金额:
    $74.4万
  • 财政年份:
    2023
  • 负责人:
    Kim Philip M
  • 依托单位:
Genome targeting by highly accurate design of Zinc Fingers to enable novel therapeutics and research tools
  • 批准号:
    477283
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Kim Philip M
  • 依托单位:
An integrated strategy for the development of next generation peptide therapeutics
  • 批准号:
    402426
  • 项目类别:
    Operating Grants
  • 资助金额:
    $53.22万
  • 财政年份:
    2019
  • 负责人:
    Kim Philip M
  • 依托单位:
A general strategy to develop inhibitors for transcription factors
  • 批准号:
    380690
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.65万
  • 财政年份:
    2018
  • 负责人:
    Kim Philip M
  • 依托单位:
海外基金